Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Cytochrome P450 2C19 Inducers [MoA]: Side Effects & Safety Data for 10 Drugs

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Cytochrome P450 2C19 Inducers [MoA] includes 10 drugs with a combined 126,799 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.

10
Drugs in Class
126,799
Combined Reports

All Cytochrome P450 2C19 Inducers [MoA] Drugs Ranked by Reports

Drug Brand Name Reports Deaths Hosp. Death Rate
ENZALUTAMIDE Xtandi 49,270 9,676 9,282 19.6%
CARBAMAZEPINE Carbamazepine 24,577 2,156 9,608 8.8%
DABRAFENIB Tafinlar 19,305 4,165 5,325 21.6%
PHENYTOIN PHENYTOIN SODIUM 14,469 1,449 5,241 10.0%
RITONAVIR Norvir 11,980 1,190 2,925 9.9%
SPARSENTAN FILSPARI 3,280 18 209 0.5%
LETERMOVIR PREVYMIS 1,416 252 398 17.8%
FOSPHENYTOIN CEREBYX 1,378 166 646 12.0%
MITAPIVAT PYRUKYND 627 4 58 0.6%
NIROGACESTAT OGSIVEO 497 7 54 1.4%

Common Side Effects in Cytochrome P450 2C19 Inducers [MoA] Drugs

Side EffectReportsDeaths
Fatigue 12,115 783
Death 10,522 10,504
Drug ineffective 10,208 733
Malignant neoplasm progression 6,400 2,190
Nausea 6,070 477
Pyrexia 5,825 522
Asthenia 5,212 546
Dizziness 5,155 258
Seizure 4,992 258
Diarrhoea 4,550 378
View detailed side effects for this class → Compare drugs in this class →